Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Sun Pharmaceutical Industries

Sun Pharmaceutical Industries

BSE: 524715|NSE: SUNPHARMA|ISIN: INE044A01036|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 26, 15:03
570.05
-21.75 (-3.68%)
VOLUME 1,055,924
LIVE
NSE
May 26, 15:03
569.75
-21.8 (-3.69%)
VOLUME 9,102,391
News on Sun Pharmaceutical Industries
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Taro recalls over 7.7k tubes of Fluocinonide cream from US

3.23 pm | 24 May 2017 |  Source: PTI

Taro Pharmaceuticals USA Inc is recalling 7,776 tubes of Fluocinonide cream, 0.05 per cent due to cross contamination with other products, the United ...

US FDA accepts application for psoriasis drug: Sun Pharma

11.16 am | 24 May 2017 |  Source: PTI

"The FDA filing acceptance follows the acceptance of the regulatory filing of tildrakizumab by the European Medicines Agency (EMA) in March 2017. Tild...

Why did pharmaceutical stocks take a hit today?

2.53 pm | 23 May 2017 |  Source: Moneycontrol.com

Individual news flow along with negative outlook for the sector by Credit Suisse hit the sector. Frontline stocks tank, pulling down the markets furth...

Market not in bubble zone but pick stocks selectively: Nilesh Shah of Kotak Mah AMC

6.15 pm | 12 May 2017 |  Source: CNBC-TV18

One could look at opportunities in spaces where the government is spending money from budgetary allocation, said Nilesh Shah of Kotak Mahindra Asset M...

Sun Pharma share price falls 3% after Dadra unit gets 11 observations from USFDA 

9.57 am | 21 Apr 2017 |  Source: Moneycontrol.com

Dadra site is the biggest unit for the compay after Halol plant, for supplying drug in the United States....

Stocks in the news: Reliance, ICICI, Wipro, Mindtree, Radico Khaitan, Diamond Power 

8.16 am | 21 Apr 2017 |  Source: CNBC-TV18

Reliance Industries | ICICI Bank | Wipro | Tata Steel | Reliance Communications | Mindtree | Indian Hotels | Spice Mobility | PVR | HDIL | Dhampur Sug...

Sun Pharma Q4 PAT may dip 0.9% to Rs 1458.4 cr: ICICI Securities

1.55 pm | 17 Apr 2017 |  Source: Moneycontrol.com

Net Sales are expected to decrease by 5.9 percent Q-o-Q (down 2.4 percent Y-o-Y) to Rs 7449.4 crore, according to ICICI Securities. Sun Pharma to repo...

Sun Pharma share price falls 3% on 11 observations from USFDA for Dadra unit 

10.52 am | 17 Apr 2017 |  Source: Moneycontrol.com

Dadra site is the biggest unit after Halol for Sun Pharma for US supplies....

Problem with Sun Pharma may aggravate: Surajit Pal 

10.12 am | 17 Apr 2017 |  Source: CNBC-TV18

NULL...

Stocks in the news: IOC, Cipla, Nestle, Indian Hume Pipe, Reliance Power

8.11 am | 17 Apr 2017 |  Source: CNBC-TV18

IOC | Cipla | Nestle | Indian Hume Pipe | Reliance Power are stocks, which are in news today....

Hold Sun Pharmaceutical; target of Rs 680: Axis Direct

6.01 pm | 23 Feb 2017 |  Source: Moneycontrol.com

Axis Direct recommended hold rating on Sun Pharmaceutical with a target price of Rs 680 in its research report dated February 21, 2017....

Buy Sun Pharma; target of Rs 810: Centrum

5.08 pm | 23 Feb 2017 |  Source: Moneycontrol.com

Centrum is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 810 in its research report dated February 15, 2017....

Buy Sun Pharma; target of Rs 850: HDFC Securities

4.37 pm | 22 Feb 2017 |  Source: Moneycontrol.com

HDFC Securities is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 850 in its research report dated February 1...

Buy Sun Pharmaceutical; target of Rs 832: Khambatta Securities

12.47 pm | 20 Feb 2017 |  Source: Moneycontrol.com

Khambatta Securities is bullish on Sun Pharmaceutical has recommended buy rating on the stock with a target price of Rs 832 in its research report dat...

Buy Sun Pharmaceuticals; target of Rs 860: Edelweiss

1.47 pm | 16 Feb 2017 |  Source: Moneycontrol.com

Edelweiss is bullish on Sun Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 860 in its research report dated Februar...

Ranbaxy deal to kick in, Halol overhang on Sun Pharma:Brokerages

3.48 pm | 15 Feb 2017 |  Source: Moneycontrol.com

Most analysts noted that the Q3 results were below their estimates, but maintained their buy rating on the stock revising the target price slightly on...

Sun Pharma Q3 profit dragged by slowdown in US & India sales 

3.25 pm | 14 Feb 2017 |  Source: Moneycontrol.com

US generics business that accounts for nearly half of Sun Pharma sales grew at a moderate pace of 4 percent USD 507 million in the third quarter. ...

Sun Pharma Q3 profit seen up 27%; US & India biz may grow 10% 

5.47 pm | 13 Feb 2017 |  Source: CNBC-TV18

According to average of estimates of analysts polled by CNBC-TV18, revenue during the quarter may increase 11.6 percent year-on-year to Rs 7,905.3 cro...

Lupin pins hopes on new launches in US to fend off rivals

8.17 pm | 09 Feb 2017 |  Source: Moneycontrol.com

The company said it plans to mitigate the any loss in revenue from Glumetza and Fortamet with over 25 potential launches in the next 12 months - inclu...

Good Q3 but Dr Reddy's still far from sustainable growth: Expert 

11.25 am | 06 Feb 2017 |  Source: CNBC-TV18

Surajit Pal, Research Analyst at Prabhudas Lilladher, said the pharma sector is undergoing a transition and all the large midcaps will underperform....

1 2 3 4 5 6 7 8
Quick Links for Sun Pharmaceutical Industries
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.